Comparison of hepatitis B surface antigen and e antigen in predicting liver histology in hepatitis B e antigen-positive chronic hepatitis B patients-Reference-Cited by-同舟云学术

Comparison of hepatitis B surface antigen and e antigen in predicting liver histology in hepatitis B e antigen-positive chronic hepatitis B patients

Published:2014-01-23 Issue:2 Volume:8 Page:216-223
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Wang Hong,Yan Rong,Zhou Yin,Wang Ming Shan,Ruo Guo Qin,Cheng Mei Juan

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-013-9502-8.pdf

Reference29 articles.

1. Chan HL, Wong GL, Wong VW. A review of the nature history of chronic hepatitis B in the era of transient elastography. Antivir Ther 2009;14:489–499

2. European association for the study of the liver. EASL clinical practice guideline: management of chronic hepatitis B. J Hepatol 2009;50:227–242

3. Ganem D, Prince AM. Hepatitis B virus infection: natural history and clinical consequences. N Engl J Med 2004;350:1118–1129

4. Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology 2012;142:1140–1149

5. Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008;134:1376–1384

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients;Gastroenterología y Hepatología;2020-11

2. Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients;Gastroenterología y Hepatología (English Edition);2020-11

3. Role of quantitative hepatitis B surface antigen levels in predicting liver biopsy time in treatment-naive chronic hepatitis B patients;Clinical and Experimental Hepatology;2020

4. A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels;Disease Markers;2018-10-14

5. Development and validation of a model for staging hepatic fibrosis for chronic hepatitis B patients with E antigen-positive;Oncotarget;2017-10-24